MD, MBA, Board member
Currently Director and CEO of Imevax GmbH, Jim (James) Phillips has held a number of Non-executive directorships in Europe including Insense Ltd and Healthcare Brands International Ltd. Previously he was e.g. CEO for Midatech, President of EUSA Pharma Europe in its key growth phase prior to its sales in 2012 to Jazz Pharma, CEO & founder in Talisker Pharma (sold in 2006 to EUSA Pharma) and also SVP Corporate Development at EUSA; he founded Talisker Pharma in 2004 which was acquired by EUSA in 2006. Jim previously worked for Johnson & Johnson and Novartis as a senior executive. Phillips has been a board member of Herantis since 2014.